Luteal Phase Commencing of Growth Hormone

Gulhane School of Medicine

Status: Completed

Conditions: Infertility

Treatments: Drug: Norditropin pen

Study type: Observational

Funder types: Other

Identifiers

NCT00561769

GATA 2005-21

Details and patient eligibility

About

Commencing of growth hormone in luteal phase when follicular cohort for the next cycle is being gathered may increase mature oocytes in poor responder

Enrollment: 61 patients

Sex: Female

Ages: 20 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Poor responder

Exclusion criteria

• FSH >20 IU

Trial design

61 participants in 1 patient group

A

Description:

poor responder

Treatment:

Drug: Norditropin pen